EUVIMEDEUVIMED entdecken
Multizentrische StudieEvaluationsstudieOpen Access · CC BY 4.0

Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis

Potiandi Serge Diagbouga iD, Arthur Diakourga Djibougou iD, Camille Pease iD, Ariana Alcaide, Audrey Berthoux, Natalie Bruiners, Daniela Maria Cirillo iD, Ardjouma Combary, Nadine Falchero, Deborah Handler, Antoinette Kaboré iD, Alfred Lardizabal und 14 weitere

Journal of Clinical Microbiology · 11.06.2025 · 63 (6)

DOI: 10.1128/jcm.01641-24 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 11.06.2025. Verfasst von Potiandi Serge Diagbouga und 25 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Recherche en Sciences de la Santé, Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouagadougou, Burkina Faso. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Interferon-gamma Release Tests, Latent Tuberculosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This preliminary study compares VIDAS TB-IGRA (bioMérieux, Marcy-l'Etoile, France) with the established QuantiFERON-TB Gold Plus (QFT-Plus) (Qiagen, Hilden, Germany) to evaluate diagnostic performance for the diagnosis of individuals infected with Mycobacterium tuberculosis complex (latent infection and disease). The study was multi-center and performed between 2 October 2019 and 4 February 2020. Participants were divided into tuberculosis (TB) disease, high-risk, and low-risk populations. The confirmed TB disease population included 104 patients. The high-risk population included 162 individuals with flagged risk factors on a questionnaire but without objective clinical confirmation of TB. The low-risk population included 117 healthy blood donors from the French National Blood Bank. Positive and negative percent agreement (PPA and NPA) were determined between the VIDAS TB-IGRA and QFT-Plus. In the TB disease population, sensitivity was measured against bacterial culture and PCR. The VIDAS TB-IGRA produced fewer indeterminate results than the QFT-Plus (1/104 vs 23/104) in the TB disease population and exhibited a sensitivity of 95.0% against bacterial culture. Furthermore, a 98.2% PPA was obtained in comparison to QFT-Plus. In the low-risk population, the VIDAS TB-IGRA demonstrated high specificity (94.9%) and a strong NPA (98.2%) compared to QFT-Plus. In the high-risk population, the VIDAS TB-IGRA exhibited a strong PPA (94.4%) with the QFT-Plus. A lower NPA was observed (85.2%) compared to QFT-Plus, which may be due to a higher sensitivity demonstrated in the TB disease population. The fully automated VIDAS TB-IGRA is a promising aid in the diagnosis of individuals infected with Mycobacterium tuberculosis (latent infection and active disease). It exhibits higher sensitivity while maintaining specificity and produces fewer indeterminate interpretations than QFT-Plus. Its easy-to-use, single-patient format may lead to increased TB testing to aid in the adequate diagnosis and management of the disease. IMPORTANCE This study presents a comprehensive evaluation of the VIDAS TB-IGRA diagnostic test. This test is compared with the established QuantiFERON-TB Gold Plus to assess its effectiveness in diagnosing both latent and active tuberculosis (TB) infections. The study highlights the VIDAS TB-IGRA’s higher sensitivity, fewer indeterminate results, and robust performance across different patient populations, including those with confirmed TB disease, high-risk, and low-risk groups. The findings suggest that the VIDAS TB-IGRA could enhance TB diagnosis and management, offering a fully automated, easy-to-use solution that reduces human error and result variability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisInterferon-gamma Release TestsLatent TuberculosisHumansMaleAdultSensitivity and SpecificityFemaleMiddle AgedYoung AdultAged

Stichwörter der Autor:innen

IGRAMycobacterium tuberculosis complexQFT-PlusVIDAS

Autor:innen und Institutionen

  • Institut de Recherche en Sciences de la Santé, Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouagadougou, Burkina Faso.
  • Department of Research and Development for Immunoassays, bioMerieux, Marcy-l'Étoile, Auvergne-Rhône-Alpes, France.
  • Global Tuberculosis Institute, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Public Health Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • IRCCS San Raffaele Scientific Institute, Milan, Italy.

ORCID-Profile: Potiandi Serge Diagbouga, Arthur Diakourga Djibougou, Camille Pease, Daniela Maria Cirillo, Antoinette Kaboré, Tani Sagna, Jacques Simporé, Emmanuelle Cambau, Maria Laura Gennaro

Förderung

  • Wellcome Trust

Zitieren

APA

Serge Diagbouga, P., Djibougou, A. D., Pease, C., Alcaide, A., Berthoux, A., Bruiners, N., Cirillo, D. M., Combary, A., Falchero, N., Handler, D., Kaboré, A., Lardizabal, A., Lopes, A., Loubet, M., Manivet, P., Margain, C., Meunier, V., Mougari, F., Onyuka, A., …, & Gennaro, M. L. (2025). Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis. Journal of Clinical Microbiology, 63(6). https://doi.org/10.1128/jcm.01641-24

Vancouver

Serge Diagbouga P, Djibougou AD, Pease C, Alcaide A, Berthoux A, Bruiners N, et al. Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis. Journal of Clinical Microbiology. 2025;63(6). doi:10.1128/jcm.01641-24

BibTeX
@article{SergeDiagbouga2025,
  author = {Serge Diagbouga, Potiandi and Djibougou, Arthur Diakourga and Pease, Camille and Alcaide, Ariana and Berthoux, Audrey and Bruiners, Natalie and Cirillo, Daniela Maria and Combary, Ardjouma and Falchero, Nadine and Handler, Deborah and Kaboré, Antoinette and Lardizabal, Alfred and Lopes, Amanda and Loubet, Marissa and Manivet, Philippe and Margain, Clemence and Meunier, Valerie and Mougari, Faiza and Onyuka, Alberta and Rivoiron, Sophie and Sagna, Tani and Sanvert, Mathilde and Sawadogo, Léon and Simporé, Jacques and Cambau, Emmanuelle and Gennaro, Maria Laura},
  title = {Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis},
  journal = {Journal of Clinical Microbiology},
  year = {2025},
  volume = {63},
  number = {6},
  doi = {10.1128/jcm.01641-24}
}
Kostenlos starten →